Fig. 4From: TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinomaVerification the expression of TIPARP. (a-b) Representative sections of PTC thyroid, normal tissues. The expression of TIPARP was detected by using immunohistochemistry (IHC). (c) compare of TIPARP in different tumor group. (*P < 0.05; **P < 0.01, ***P < 0.001) (ML: Male lymph node metastasis group; MN: Male non-lymph node metastasis group; FL: Female lymph node metastasis group; FN: Female non-lymph node metastasis group)Back to article page